Biocon was ahead of the curve in anticipating the critical need for affordable therapy for chronic diseases in India and other emerging markets. We deftly balanced innovation and affordability with an intent to bring cost-effective biologics, including proprietary molecules, and differentiated small molecule formulations for chronic conditions to patients.

The Branded Formulations portfolio comprises world class and differentiated products in chronic therapy areas like diabetes, oncology, nephrology, immunology and other life threatening conditions. We offer our products to patients and healthcare providers, including physicians, clinics, hospitals and pharmacies.

We have built immense brand equity with doctors and patients over the years by extending our presence into niche areas where we saw the potential to moderate costs and widen patient access.